Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment: Guidance for Industry; Availability
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 17, 2022
April 11, 2024
7511194b-76aa-4116-a433-198583956923
Related Documents
Premenopausal Women with Breast Cancer: Developing Drugs for Treatment: Guidance for Industry
Guidance DocumentJune 17, 2021Office of the Commissioner
Bladder Cancer: Developing Drugs and Biologics for Adjuvant Treatment: Guidance for Industry
Guidance DocumentJune 28, 2022Office of the Commissioner
Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment: Guidance for Industry
Guidance DocumentJune 27, 2022Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.